Cormorant Asset Management, LP
Position in GPCR — Structure Therapeutics Inc.
CIK 1583977
BOSTON, MA
Position in GPCR
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$8,435,000
-$44,827,326 QoQ
Shares Held
175,000
-83.4% QoQ
Ownership
0.082%
of shares outstanding
% of Portfolio
0.43%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2023
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GPCR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Cormorant Asset Management, LP holds $1,914,987,088 across 43 Biotechnology names. GPCR ranks #37 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PRAX |
Praxis Precision Medicines, Inc.
|
885,500 | $285,299,245 | |
| 2 | BBOT |
BridgeBio Oncology Therapeutics, Inc.
|
17,878,594 | $160,013,416 | |
| 3 | EYPT |
EyePoint, Inc.
|
8,265,000 | $106,535,850 | |
| 4 | EWTX |
Edgewise Therapeutics, Inc.
|
3,260,000 | $102,690,000 | |
| 5 | ERAS |
Erasca, Inc.
|
5,800,000 | $93,844,000 | |
| 6 | RAPP |
Rapport Therapeutics, Inc.
|
2,957,521 | $92,540,832 | |
| 7 | ALMS |
Alumis Inc.
|
3,949,241 | $87,001,779 | |
| 8 | ABVX |
Abivax S.A.
|
760,000 | $84,626,000 |
All Filings in GPCR
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $8,435,000 | 175,000 | Shares | Defined | 2026-05-15 | |
| 2023-09-30 | $53,262,326 | 1,056,373 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $23,959,825 | 576,373 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $13,711,913 | 576,373 | Shares | Defined | 2023-05-15 | |
| No filing history on record for this holder in this stock. | ||||||